1995
DOI: 10.1007/bf00198305
|View full text |Cite
|
Sign up to set email alerts
|

Influence of piroxicam coadministration on pharmacodynamic parameters and the plasma concentration/effect relationship of recombinant hirudin (CGP 39393)

Abstract: Recombinant hirudins are currently under investigation for use in myocardial infarction and unstable angina. In this study the influence of piroxicam on the pharmacodynamics and pharmacokinetics of a recombinant hirudin preparation (CGP 39393) administered intravenously was determined. Twelve healthy, male volunteers received piroxicam 10 mg and matching placebo once daily for 12 days according to a double-blind, randomised cross-over design. On the 12th day, the dose of piroxicam was followed by a 6-hour infu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0
2

Year Published

1996
1996
1998
1998

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 16 publications
0
0
0
2
Order By: Relevance
“…O pico plasmático varia entre 3 a 4h para 0,1mg/kg. O pico de efeito da hirudina sobre o tempo parcial de trombina (TTP) é de 2 a 3h 1,14 . Depois do término da infusão do fármaco, o TTP volta ao normal em 18 a 24h.…”
unclassified
See 1 more Smart Citation
“…O pico plasmático varia entre 3 a 4h para 0,1mg/kg. O pico de efeito da hirudina sobre o tempo parcial de trombina (TTP) é de 2 a 3h 1,14 . Depois do término da infusão do fármaco, o TTP volta ao normal em 18 a 24h.…”
unclassified
“…Depois do término da infusão do fármaco, o TTP volta ao normal em 18 a 24h. O volume de distribuição é de 0,23 l/kg 14 . O complexo hirudina-trombina circula no sangue entre 4 a 6h, sendo eliminado pelo sistema reticuloendotelial.…”
unclassified